Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction to stroke genomics.

Simon J Read1, Frank C Barone

  • 1AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, United Kingdom.

Methods in Molecular Medicine
|September 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic Review.

Journal of clinical medicine·2026
Same author

Advancing clinical trial readiness in white matter disease and related dementias: key steps for future research progress.

GeroScience·2025
Same author

The future of biomarkers for vascular contributions to cognitive impairment and dementia (VCID): proceedings of the 2025 annual workshop of the Albert research institute for white matter and cognition.

GeroScience·2025
Same author

Blood-based protein biomarkers during the acute ischemic stroke treatment window: a systematic review.

Frontiers in neurology·2024
Same author

Neuroprotective effect of the RNS60 in a mouse model of transient focal cerebral ischemia.

PloS one·2024
Same author

Expanding the horizon of research into the pathogenesis of the white matter diseases: Proceedings of the 2021 Annual Workshop of the Albert Research Institute for White Matter and Cognition.

GeroScience·2021
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Translating acute ischemic stroke knowledge into effective treatments remains a challenge. Integrating genetic and preclinical data is crucial for developing new therapies and improving patient outcomes.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Despite advances in understanding acute ischemic stroke, translating this knowledge into effective treatments has been slow.
  • Current therapeutic interventions like tPA have limited therapeutic windows.
  • Stroke genetics and genomics have contributed significantly to our understanding of the condition.

Purpose of the Study:

  • To discuss sources of clinical and preclinical genetic information in acute ischemic stroke.
  • To highlight the importance of integrating expression information into preclinical models.
  • To emphasize developing a functional understanding in the clinic before clinical application.

Main Methods:

  • Review of clinical and preclinical genetic information sources.

Related Experiment Videos

  • Integration of gene expression data with preclinical models.
  • Analysis of temporal and spatial roles in lesion pathology.

    • Main Results:

    • Identification of multiple sources of genetic and genomic data relevant to stroke.
    • Demonstration of the need for integrating expression data across different preclinical models.
    • Highlighting the gap between preclinical findings and clinical application.

    Conclusions:

    • A holistic integration of genetic and preclinical data is essential for advancing acute ischemic stroke treatment.
    • Improved integration will increase the yield from gene expression datasets.
    • The ultimate goal is to expand therapeutic options for physicians and patients.